Daily aspirin reduced by 55% the risk of cancer recurrence in patients whose colorectal cancer is driven by a genetic ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary syndrome (CCS) who had prior stenting and were receiving long-term ...

Emerging evidence suggests a better option already exists. A recent meta-analysis by an international team of cardiologists finds that clopidogrel – which stops blood platelets from clumping – is a ...

Early P2Y12 monotherapy after PCI for acute coronary syndrome was not noninferior compared with dual antiplatelet therapy ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...

A major trial reveals that a daily aspirin dose can significantly reduce the risk of certain colorectal cancers returning post-surgery.

Among adults with chronic rhinosinusitis with nasal polyps, asthma and NSAID-exacerbated respiratory disease, aspirin after desensitization does not benefit most patients vs. placebo, according to ...